RTW backs obesity drug firm
The manager of RTW Biotech Opportunities has led a $400m Series A financing round for a new portfolio company, Kailera Therapeutics. The announcement ...
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
The manager of RTW Biotech Opportunities has led a $400m Series A financing round for a new portfolio company, Kailera Therapeutics. The announcement ...
Syncona has committed £63.5m in a Series B financing of Resolution Therapeutics, a company focused on unlocking the regenerative potential of macropha...
In a surprise announcement, Atrato Onsite Energy says it has entered into a conditional agreement for the sale of all of its portfolio of solar assets...
In QuotedData’s morning briefing 3 October 2024: Miton UK Micro Cap (MINI) says 31,083,534 shares or 40.4% of its issued share capital, has been put f...
Starling Bank, a 30% holding for Chrysalis Investments, avoids a £41m penalty from the Financial Conduct Authority for ‘shockingly lax’ controls.
The regulator confirms that investment firms can stop showing flawed key information documents, but says all companies in the ‘distribution chain’ must treat consumers fairly.
Witan shareholders overwhelmingly back a merger with Alliance Trust. Only a small number opt for cash, leaving the £4.8bn entity almost certain to enter the FTSE 100.
The outspoken former Scottish Mortgage fund manager is ‘surprised’ by the spectacular recent rally in China and says he didn’t get the autonomy he needed at Baillie Gifford.
Top-performing JP Morgan flagship adds to defensive companies after seeing signs of a slowdown in the US.
VietNam Holding (VNH) announced its annual report for the twelve-months to 30 June 2024. The company delivered an impressive NAV total return of 23.6...
Alternative Income REIT (AIRE) has posted a 3.9% drop in net asset value (NAV) to 80.9p in annual results to 30 June 2024. The fall was primarily due ...
In QuotedData’s morning briefing 2 October 2024: RTW Biotech Opportunities (RTW) announced a new investment in Aktis Oncology, a clinical-stage biotec...
Developed by Moore-Wilson